A process for the manufacture of the anaesthetic compound CHF.sub.2 --O--CHF--CHF.sub.2 which comprises the reduction of a mono, di- or tri-chlorinated or brominated derivative of the above compound, or the replacement by fluorine of one or more hydrogen, chlorine or bromine atoms in a less-fluorinated derivative of the above compound.